Conservative treatment for patients over 80 years with acute myelogenous leukemia

American Journal of Hematology

Volumn 71, Issue 4, 2002, Pages 256-259

  Latagliata, Roberto ^a,d   Alimena, Giuliana ^a   Carmosino, Ida ^a   Breccia, Massimo ^a   Borza, Paola Anticoli ^a   Bongarzoni, Velia ^a   Copia, Carolina ^b   Spadea, Antonio ^c   Pinazzi, Beatrice ^a   Frattarelli, Natalia ^a   Ferrara, Felicetto ^b   Petti, Maria Concetta ^c   Mandelli, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d Cattedra di Ematologia   (Italy)

Author keywords

Acute myelogenous leukemia; Conservative treatment; Elderly

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CYTARABINE; HYDROXYUREA; MERCAPTOPURINE; STEROID; TIOGUANINE; TRANEXAMIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLEEDING; BONE MARROW HYPOPLASIA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CAUSE OF DEATH; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOCYTOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT INDICATION;

EID: 0036891936     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10235     Document Type: Article

References (10)

1. Brincker H. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age specific rates of incidence and of complete remission. Cancer Treat Rep 1985;69:5-11.
2. Paccaud F, Sidoti Pinto C, Marazzi A, Mili J. Age at death and rectangularisation of the survival curve: Trends in Switzerland, 1969-1994. J Epidemiol Community Health 1998;52:412-415.
3. Latagliata R, Petti MC, Mandelli F. Acute myeloid leukemia in the elderly: "Per aspera ad astra". Leuk Res 1999;23:603-613.
4. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986;80:435-442.
5. Tamburrini LR, Di Monte M, Geromella R, Ponte E, Cherubini M. The aging heart and its pathology. An epidemiological study of 229 cases based on a clinical and radiological classification. Minerva Med 1989;80:1275-1282.
6. DeLima M, Ghaddar H, Pierce S, Estey E. Treatment of newly diagnosed acute myelogenous leukemia in patients aged 80 years or above. Br J Haematol 1996;93:89-95.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 1985;103:620-625.
8. Griffin JD, Spriggs D, Wisch JS, Kafe DW. Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside. J Clin Oncol 1985;3:982-991.
9. Takeyama H, Yamamoto Y, Miyata Y, Yamada H, Watanabe E, Aoki H, Iinuma M. Treatment of acute myelogenous leukemia in patients more than 80 years old. Gan To Kagaku Ryoho 1997;24:1089-1093.
10. Ferrara F, Annunziata M, Copia C, Magrin S, Mele G, Mirto S. Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia. Haematologica 1998;83:126-131.